Fortress Biotech, Inc. (FBIO) Earnings History
Annual and quarterly earnings data from 2009 to 2024
Loading earnings history...
FBIO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
FBIO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 63.8% | -191.4% | -79.8% |
| 2023 | 72.9% | -168.4% | -71.7% |
| 2022 | 59.4% | -268.8% | -114.3% |
| 2021 | 53.4% | -274.1% | -94.1% |
| 2020 | 68.0% | -206.7% | -102.0% |
Download Data
Export FBIO earnings history in CSV or JSON format
Free sign-in required to download data
Fortress Biotech, Inc. (FBIO) Earnings Overview
As of May 8, 2026, Fortress Biotech, Inc. (FBIO) reported trailing twelve-month net income of $4M, reflecting +68.2% year-over-year growth. The company earned $0.12 per diluted share over the past four quarters, with a net profit margin of -79.8%.
Looking at the long-term picture, FBIO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2009.
Fortress Biotech, Inc. maintains positive profitability with a gross margin of 63.8%, operating margin of -191.4%, and net margin of -79.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including XOMA ($29M net income, 60.8% margin), RCUS (-$369M net income, -142.9% margin), ROIV (-$809M net income, -592.0% margin), FBIO has room to improve margins relative to the peer group. Compare FBIO vs XOMA →
FBIO Earnings vs Peers
Earnings metrics vs comparable public companies
FBIO Historical Earnings Data (2009–2024)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$46M | +24.1% | -$110M | $-2.69 | -79.8% | -191.4% |
| 2023 | -$61M | +30.0% | -$142M | $-8.47 | -71.7% | -168.4% |
| 2022 | -$87M | -33.8% | -$204M | $-14.55 | -114.3% | -268.8% |
| 2021 | -$65M | -39.1% | -$189M | $-11.85 | -94.1% | -274.1% |
| 2020 | -$47M | -16.4% | -$94M | $-9.75 | -102.0% | -206.7% |
| 2019 | -$40M | +52.5% | -$111M | $-10.95 | -109.1% | -302.5% |
| 2018 | -$84M | -25.8% | -$120M | $-29.04 | -313.0% | -446.4% |
| 2017 | -$67M | -21.4% | -$90M | $-24.08 | -35.7% | -47.9% |
| 2016 | -$55M | -13.8% | -$66M | $-20.68 | -334.3% | -398.7% |
| 2015 | -$48M | -137.6% | -$51M | $-18.56 | -5611.6% | -5855.3% |
See FBIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FBIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FBIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFBIO — Frequently Asked Questions
Quick answers to the most common questions about buying FBIO stock.
Is FBIO growing earnings?
FBIO EPS is $0.12, with earnings growth accelerating to +68.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $4M.
What are FBIO's profit margins?
Fortress Biotech, Inc. net margin is -79.8%, with operating margin at -191.4%. Below-average margins reflect competitive or cost pressures.
How consistent are FBIO's earnings?
FBIO earnings data spans 2009-2024. The accelerating earnings trend is +68.2% YoY. Historical data enables comparison across business cycles.